MAIA Biotechnology Awarded $2.3 Million Grant by National
THIO-101 Phase 2 trial to enroll patients in the U.S. as part of the expansion of the study in third-line treatment for advanced non-small cell lung cancer (NSCLC) CHICAGO, Sept.…
$7.5 million grant to guard against AI-driven misinformation: IU News
BLOOMINGTON, Ind. — Indiana University researchers will lead a multi-institutional team of experts in areas such as informatics, psychology, communications and folklore to assess the role that artificial intelligence may…
